Drug-induced hepatotoxicity: Clinical and biochemical features of 26 patients and a review of the literature;Epatotossicità da farmaci. Casistica e revisione della letteratura

Recenti Progressi in Medicina

Volumn 102, Issue 6, 2011, Pages 253-260

  Mengoli, Marco ^a   Parmeggiani, Davide ^b   Mengoli, Maria Cecilia ^c   Grinzi, Giorgia ^b   Tolomelli, Stefano ^a  

^a Ospedale San Sebastiano   (Italy)

^b Ospedale Ramazzini   (Italy)

^c UNIVERSITY OF CATANIA   (Italy)

Author keywords

Acute cholestatic hepatitis; Acute cytotoxic hepatitis; Drug induced hepatotoxicity; Herbal remedies hepatotoxicity

Indexed keywords

HERBACEOUS AGENT;

ADULT; ARTICLE; BIOCHEMISTRY; CLINICAL ARTICLE; CLINICAL FEATURE; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG INDUCED HEPATOTOXICITY; DRUG SAFETY; FEMALE; HERBAL MEDICINE; HUMAN; LIVER TOXICITY; MALE; MEDICAL HISTORY; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; DIETARY SUPPLEMENTS; DRUG-INDUCED LIVER INJURY; DRUGS, CHINESE HERBAL; EARLY DIAGNOSIS; FEMALE; HUMANS; IATROGENIC DISEASE; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; PHYTOTHERAPY; RETROSPECTIVE STUDIES; WITHHOLDING TREATMENT;

EID: 79960459821     PISSN: 00341193     EISSN: 20381840     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Koff RS, Gardner R, Harinasuta U, Phil CO. Profile of hyperbilirubinemia in three hospital populations. Clin Res 1970; 18: 680-7.
2. Knill-Jones RP, Stern DH, Girmes DH, Maxwell JD, Thompson RPH, Williams R. Use of sequential bayesian model in diagnosis of jaundice by computer. Br Med J 1973; 1: 530-3.
3. Jones JK. Suspected drug-induced hepatic reactions reported to the FDA's adverse reaction system: an overview. Sem Liver Dis 1981; 1: 157-62.
4. Danan G, Benhamou JP. Les atteintes hepatiques medicamenteuses. Presse Med 1986; 20: 909-10. (Pubitemid 16037081)
5. Agarwal VK, McHutchison JG, Hoofnagle JH. Important elements for the diagnosis of drug-induced liver injury. Clin Gastroenterol Hepatol 2010; 8: 463-70.
6. Ostapowicz G, Fontana RJ, Schiodt FV, et al. Results of a prospective study of acute liver failure at 17 tertiary Care Centers in the United States. Ann Intern Med 2002; 137: 947-54.
7. Larrey D. Hepatotoxicity of drugs and chemicals. Gastroenterol Clin Biol 2009; 33: 1136-46.
8. Biour M, Ben Salem C, Chazouilleres O, et al. Hepatotoxicité des medicaments: 14° mise a jour du fichier bibliographique des atteintes hepatiques et des medicaments responsables. Gastroenterol Clin Biol 2004; 28: 720-59. (Pubitemid 39318162)
9. Mengoli M, Marchi M, Tolomelli S, Bagnulo A. Epatite acuta da cyclofenil. Diagnosi retrospettiva di un caso in corso di epatite acuta da virus B. Recenti Prog Med 1991; 82: 236-9.
10. Gollini C, Dallari R, Cervi F, Mengoli M. Epatite acuta da iproniazide. Recenti Prog Med 1992; 88: 354-5.
11. Aithal PG, Day CP. The natural history of histologically proved drug: induced liver disease. Gut 1999, 44: 731-5. (Pubitemid 29195925)
12. Desmet VJ. Vanishing bile duct syndrome in drug-induced liver disease. J Hepatol 1997, 26: 31-5. (Pubitemid 127777235)
13. Kubin CJ, Sherman O, Hussain KB, Feinman L. Delayed onset ticlopidine-induced cholestatic jaundice. Pharmacotherapy 1999; 18: 1006-10. (Pubitemid 29377322)
14. Placci A, Melandri G, Cecilioni L, et al. Ittero colestatico a comparsa ritardata dopo un trattamento per un mese con ticlopidina. Ital Heart J 2001; 2: 1240-2.
15. Koff RS. Herbal hepatotoxicity. Revisiting a dangerous alternative. JAMA 1995; 273: 502.
16. Lasser KE, Allen PD, Woolhandler SJ, et al. Timing of new black box warnings and withdrawals for prescription medications. JAMA 2002; 287: 2215-20. (Pubitemid 34441937)
17. Sgro C, Clinard F, Ouazir K, et al. Incidence of drug-induced hepatic injuries: a French population-based study. Hepatology 2002; 36: 451-5. (Pubitemid 34810366)
18. Shenker S, Martin RR, Hoyumpa AM. Antecedent liver disease and drug toxicity. J Hepatol 1999; 31: 1098-105.
19. Stickel F, Brinkhaus B, Krahmer N, Seitz HK, et al. Antifibrotic properties of botanicals in chronic liver disease. Hepatogastroenterology 2002; 49: 1102-8. (Pubitemid 34809798)
20. De Smet PAGM. Herbal remedies. New Engl J Med 2002; 347: 2046-56. (Pubitemid 35461662)
21. De Smet PAGM. Health risks of herbal remedies. Drug Saf 1995; 13: 81-93.
22. Estes JD, Stolpman D, Olyaei A, et al. High prevalence of potentially hepatotoxic herbal supplement use in patients with fulminant hepatic failure. Arch Surg 2003; 138: 852-8. (Pubitemid 36960946)
23. Huang WF, Wen KC, Hsiao ML. Adulteration by synthetic therapeutic substances of traditional Chinese medicines in Taiwan. J Clin Pharmacol 1997; 37: 334-50.
24. Ernst E. Adulteration of Chinese herbal medicines with synthetic drugs: a systematic review. J Internal Med 2002; 252: 107-13. (Pubitemid 34989271)